Advanced glycation end-product formation precursor

Advanced glycation end-product formation precursors are a diverse group of reactive small molecules, mainly α-dicarbonyl compounds (like methylglyoxal and glyoxal), that initiate non-enzymatic glycation by reacting with proteins, lipids, or nucleic acids to form AGEs[1][2][3][4]. These precursors are central to metabolic dysfunction in diabetes, aging, and other chronic conditions by inducing alterations in protein structure, cellular signaling, and promoting inflammation and oxidative stress[3][5][7]. Therapeutic approaches target their formation, detoxification, and downstream actions but these molecules themselves are not conventional pharmacological targets[2][6].

Other names

AGE precursorsglycation intermediatesα-dicarbonyl compounds (such as methylglyoxal, glyoxal, 3-deoxyglucosone)

Inhibition of AGE precursor formation/reactivity slows downstream glycation and AGE accumulation. Scavenging of carbonyl compounds prevents protein modification. Enzyme upregulation (glyoxalase system detoxifies methylglyoxal/glyoxal).